La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Eris Lifesciences Gestion
Gestion contrôle des critères 4/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Amit Bakshi
Directeur général
₹48.8m
Rémunération totale
| Pourcentage du salaire du PDG | 35.9% |
| Durée du mandat du directeur général | 17.6yrs |
| Propriété du PDG | 42.9% |
| Durée moyenne d'occupation des postes de direction | 7.9yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 3.8yrs |
Mises à jour récentes de la gestion
Recent updates
Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Aug 05
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Aug 04Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)
Jul 13Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
May 24Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price
May 10An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued
Mar 14Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report
Feb 15Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)
Dec 28Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Dec 07Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Nov 11Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Jul 20Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?
Nov 20These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely
Jun 20A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)
Feb 24Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?
Dec 28Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today
Sep 23If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late
May 26Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Apr 17Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?
Mar 12Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?
Feb 25Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar
Feb 12Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results
Jan 30
Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares
Jan 17Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay
Dec 30Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?
Dec 10Eris Lifesciences (NSE:ERIS) Shareholders Booked A 25% Gain In The Last Year
Nov 23Is It Worth Buying Eris Lifesciences Limited (NSE:ERIS) For Its 1.1% Dividend Yield?
Oct 22How Does Eris Lifesciences' (NSE:ERIS) CEO Salary Compare to Peers?
Oct 01How Much Are Eris Lifesciences Limited (NSE:ERIS) Insiders Taking Off The Table?
Sep 14Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹4b |
| Mar 31 2024 | n/a | n/a | ₹4b |
| Dec 31 2023 | n/a | n/a | ₹4b |
| Sep 30 2023 | n/a | n/a | ₹4b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹49m | ₹17m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹46m | ₹26m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹4b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹27m | ₹27m | ₹4b |
| Dec 31 2020 | n/a | n/a | ₹3b |
| Sep 30 2020 | n/a | n/a | ₹3b |
| Jun 30 2020 | n/a | n/a | ₹3b |
| Mar 31 2020 | ₹49m | ₹18m | ₹3b |
| Dec 31 2019 | n/a | n/a | ₹3b |
| Sep 30 2019 | n/a | n/a | ₹3b |
| Jun 30 2019 | n/a | n/a | ₹3b |
| Mar 31 2019 | ₹49m | ₹18m | ₹3b |
| Dec 31 2018 | n/a | n/a | ₹3b |
| Sep 30 2018 | n/a | n/a | ₹3b |
| Jun 30 2018 | n/a | n/a | ₹3b |
| Mar 31 2018 | ₹49m | ₹11m | ₹3b |
Rémunération vs marché: La rémunération totale de Amit ($USD 581.61K ) est dans la moyenne des entreprises de taille similaire sur le marché Indian ($USD 473.89K ).
Rémunération et revenus: La rémunération de Amit a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Amit Bakshi (48 yo)
17.6yrs
Titularisation
₹48,776,648
Compensation
Mr. Amit Indubhushan Bakshi serves as Chairman and Managing Director at Eris Lifesciences Limited. Mr. Bakshi has an extensive experience of Indian Pharmaceutical industry and handles Strategic Management...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman & MD | no data | ₹48.78m | 42.87% ₹ 70.6b | |
| President | no data | ₹12.31m | pas de données | |
| Chief Financial Officer | 7.9yrs | ₹14.35m | pas de données | |
| Executive Director & COO | 3.3yrs | ₹44.85m | pas de données | |
| Compliance Officer & Company Secretary | 7.9yrs | pas de données | pas de données | |
| President of Sales & Marketing | no data | ₹11.24m | pas de données | |
| Executive Director | no data | ₹12.40m | 4.36% ₹ 7.2b | |
| Whole Time Director | no data | ₹6.99m | 3.28% ₹ 5.4b | |
| Senior Vice President | no data | ₹12.64m | pas de données | |
| Vice President | no data | ₹13.30m | pas de données | |
| Vice President | no data | ₹10.67m | pas de données | |
| Vice President | no data | ₹13.12m | pas de données |
7.9yrs
Durée moyenne de l'emploi
50.5yo
Âge moyen
Gestion expérimentée: L'équipe de direction de ERIS est chevronnée et expérimentée (ancienneté moyenne 7.9 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman & MD | 17.6yrs | ₹48.78m | 42.87% ₹ 70.6b | |
| Executive Director & COO | 3.7yrs | ₹44.85m | pas de données | |
| Executive Director | 17.6yrs | ₹12.40m | 4.36% ₹ 7.2b | |
| Whole Time Director | 4yrs | ₹6.99m | 3.28% ₹ 5.4b | |
| Independent Director | 6.3yrs | ₹3.98m | pas de données | |
| Independent Director | 2.1yrs | ₹2.82m | pas de données | |
| Independent Director | 3.6yrs | ₹4.53m | pas de données | |
| Independent Director | 3.7yrs | ₹4.20m | pas de données |
3.8yrs
Durée moyenne de l'emploi
50.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de ERIS sont considérés comme expérimentés (ancienneté moyenne 3.8 ans).